Courtet P

Psychiatry, CHU Montpellier , ,

5 papers · ORCID

ArticlePsilocybin

One dose of Psilocybin modulates Brain Activity among Depressive patients : Preliminary Neuroimaging Results from the PSILODAC Study

Pastre M, Pereira F, Gibert T +6

Europe PMC2026
ArticleKetamine

Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study.

de Granda-Beltrán AM, Porras-Segovia A, Núñez-Arias D +5

Europe PMC2026
ArticleKetamine

Esketamine use in real-world clinical practice in patients with treatment-resistant depression.

Conejero I, Alvarez García R, Porras-Segovia A +7

Europe PMC2025
ArticlePsilocybin

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

Strumila R, Nobile B, Korsakova L +5

Europe PMC2021
ArticlePsilocybin

Commentary: Psychedelic Psychiatry's Brave New World.

Nobile B, Olié E, Courtet P

Europe PMC2020